This study aims that oxidative stress and inflammation status in children and adolescents with attention deficit hyperactivity disorder (ADHD) compared to their healthy peers.
Method:
Thirty ADHD and healthy controls were included in this study. ADHD diagnosis according to the DSM-V and Conners’ teacher and parent rating scale by a structured psychiatric interview. Total oxidant status (TOS), total antioxidant status (TAS), and total and native thiol levels were determined using photometric methods. Presepsin, Interleukin (IL) 1-ß, IL-6, and Tumor Necrosis Factor-alpha (TNF-α) levels were measured with commercial ELISA kits.
Results:
We showed that TOS and oxidative stress index were significantly higher in the ADHD group, and TAS was lower than in the control group (p<.001). Similarly, IL1-ß, IL-6, and TNF-α levels were statistically higher in the ADHD group. Backward LR regression analysis reveals that TOS and IL-6 predicted ADHD.
Conclusion:
TOS and IL-6 levels may play a role in the pathogenesis of ADHD.
AnandD.ColpoG. D.ZeniG.ZeniC. P.TeixeiraA. L. (2017). Attention-deficit/hyperactivity disorder and inflammation: What does current knowledge tell us? A systematic review. Frontiers in Psychiatry, 8, 228. https://doi.org/10.3389/FPSYT.2017.00228
2.
AvshalumovM. V.RiceM. E. (2003). Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proceedings of the National Academy of Sciences of the United States of America, 100(20), 11729–11734. https://doi.org/10.1073/PNAS.1834314100
3.
BulutM.SelekS.GergerliogluH. S.SavasH. A.YilmazH. R.YuceM.EkiciG. (2007). Malondialdehyde levels in adult attention-deficit hyperactivity disorder. Journal of Psychiatry & Neuroscience, 32(6), 435.
4.
CeylanM.SenerS.BayraktarA. C.KavutcuM. (2010). Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(8), 1491–1494. https://doi.org/10.1016/J.PNPBP.2010.08.010
5.
ChangJ. P. C.MondelliV.SatyanarayananS. K.ChiangY. J.ChenH. T.SuK. P.ParianteC. M. (2020). Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan. Brain, Behavior, and Immunity, 88, 105–113. https://doi.org/10.1016/J.BBI.2020.05.017
6.
CoronaJ. C. (2020). Role of oxidative stress and neuroinflammation in attention-deficit/hyperactivity disorder. Antioxidants, 9(11), 1039. https://doi.org/10.3390/ANTIOX9111039
7.
CorteseS.Moreira-MaiaC. R.St. FleurD.Morcillo-PeñalverC.RohdeL. A.FaraoneS. V. (2016). Association between ADHD and obesity: A systematic review and meta-analysis. American Journal of Psychiatry, 173(1), 34–43. https://doi.org/10.1176/appi.ajp.2015.15020266
8.
DarwishA. H.ElgoharyT. M.NosairN. A. (2019). Serum interleukin-6 level in children with attention-deficit hyperactivity disorder (ADHD). Journal of Child Neurology, 34(2), 61–67. https://doi.org/10.1177/0883073818809831
9.
de Araújo BoletiA. P.de Oliveira FloresT. M.MorenoS. E.AnjosL.dos, MortariM. R.MiglioloL. (2020). Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies. Neurochemistry International, 136, 104714. https://doi.org/10.1016/J.NEUINT.2020.104714
10.
DonfrancescoR.NativioP.BorrelliE.GiuaE.AndriolaE.VillaM. P.DitraniM. (2021). Serum cytokines in pediatric neuropsychiatric syndromes: Focus on Attention Deficit Hyperactivity Disorder. Minerva Pediatrics, 73(5), 398–404. https://doi.org/10.23736/S2724-5276.16.04642-9
11.
DonfrancescoR.NativioP.Di BenedettoA.VillaM. P.AndriolaE.MelegariM. G.CiprianoE.Di TraniM. (2020). Anti-Yo antibodies in children with ADHD: First results about serum cytokines. Journal of Attention Disorders, 24(11), 1497–1502. https://doi.org/10.1177/1087054716643387
12.
DunnG. A.NiggJ. T.SullivanE. L. (2019). Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacology, Biochemistry, and Behavior, 182, 22. https://doi.org/10.1016/J.PBB.2019.05.005
13.
EdlowA. G. (2017). Maternal obesity and neurodevelopmental and psychiatric disorders in offspring. Prenatal Diagnosis, 37(1), 95. https://doi.org/10.1002/PD.4932
14.
ErelO. (2004). A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry, 37(4), 277–285. https://doi.org/10.1016/J.CLINBIOCHEM.2003.11.015
GuneyE.CetinF. H.AlisikM.TuncaH.Tas TorunY.IseriE.Isik TanerY.CayciB.ErelO. (2015). Attention deficit hyperactivity disorder and oxidative stress: A short term follow up study. Psychiatry Research, 229(1–2), 310–317. https://doi.org/10.1016/J.PSYCHRES.2015.07.003
18.
HaririM.DjazayeryA.DjalaliM.SaedisomeoliaA.RahimiA.AbdolahianE. (2012). Effect of n-3,mentation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder. Malaysian Journal of Nutrition, 18(3), 329–335.
19.
JosephN.Zhang-JamesY.PerlA.FaraoneS. V. (2015). Oxidative stress and ADHD: A meta-analysis. Journal of Attention Disorders, 19(11), 915. https://doi.org/10.1177/1087054713510354
20.
Karababaİ. F.SavasS. N.SelekS.CicekE.CicekE. I.AsogluM.BayazitH.KandemirH.KatiM.UlasT. (2017). Homocysteine levels and oxidative stress parameters in patients with adult ADHD. Journal of Attention Disorders, 21(6), 487–493. https://doi.org/10.1177/1087054714538657
21.
KulM.UnalF.KandemirH.SarkaratiB.KilincK.KandemirS. B. (2015). Evaluation of oxidative metabolism in child and adolescent patients with attention deficit hyperactivity disorder. Psychiatry Investigation, 12(3), 361–366. https://doi.org/10.4306/PI.2015.12.3.361
22.
KurhanF.AlpH. H. (2021). Dynamic thiol/disulfide homeostasis and oxidative DNA damage in adult attention deficit hyperactivity disorder. Clinical Psychopharmacology and Neuroscience, 19(4), 731. https://doi.org/10.9758/CPN.2021.19.4.731
23.
LuoY.WeibmanD.HalperinJ. M.LiX. (2019). A review of heterogeneity in attention deficit/hyperactivity disorder (ADHD). Frontiers in Human Neuroscience, 13, 42. https://doi.org/10.3389/FNHUM.2019.00042
24.
MartinA.BlochM. H.VolkmarR. F. (2018). Attention-deficit hyperactivity disorder. In ReyJ. M.MartinA. (Eds.), Lewis’s child and adolescent psychiatry, a comprehensive textbook (5th ed.) (p. 1008). International Association for Child and Adolescent Psychiatry and Allied Professions.
25.
MoniczewskiA.GawlikM.SmagaI.NiedzielskaE.KrzekJ.PrzegalińskiE.PeraJ.FilipM. (2015). Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacological Reports, 67(3), 560–568. https://doi.org/10.1016/J.PHAREP.2014.12.014
26.
NasimS.NajafiM.GhazviniM.HassanzadehA.NaeiniA. A. (2019). Relationship between antioxidant status and attention deficit hyperactivity disorder among children. International Journal of Preventive Medicine, 10(1), 1–5. https://doi.org/10.4103/IJPVM.IJPVM_80_18
27.
OadesR. D. (2011). An exploration of the associations of pregnancy and perinatal features with cytokines and tryptophan/kynurenine metabolism in children with attention-deficit hyperactivity disorder (ADHD). Attention Deficit and Hyperactivity Disorders, 3(4), 301–318. https://doi.org/10.1007/S12402-011-0062-2
28.
OadesR. D.DauvermannM. R.SchimmelmannB. G.SchwarzM. J.MyintA. M. (2010). Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism–effects of medication. Behavioral and Brain Functions, 6, 29. https://doi.org/10.1186/1744-9081-6-29
29.
OadesR. D.MyintA. M.DauvermannM. R.SchimmelmannB. G.SchwarzM. J. (2010). Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention. Behavioral and Brain Functions, 6. https://doi.org/10.1186/1744-9081-6-32
30.
ÖğütlüH.MertoğluC.GökG.NeşelioğluS. (2020). Thiols and ceruloplasmin levels in serum of children with attention deficit hyperactivity disorder: A cross-sectional study. Psychiatry Research, 294, 113546. https://doi.org/10.1016/J.PSYCHRES.2020.113546
SelekS.BulutM.OcakA. R.KalenderoĝluA.SavaşH. A. (2012). Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. Journal of Psychiatric Research, 46(4), 451–455. https://doi.org/10.1016/J.JPSYCHIRES.2011.12.007
33.
SezenH.KandemirH.SavikE.Basmacı KandemirS.KilicaslanF.BilincH.AksoyN. (2016). Increased oxidative stress in children with attention deficit hyperactivity disorder. Redox Report: Communications in Free Radical Research, 21(6), 248–253. https://doi.org/10.1080/13510002.2015.1116729
34.
Solleiro-VillavicencioH.Rivas-ArancibiaS. (2018). Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4 + T cells in neurodegenerative diseases. Frontiers in Cellular Neuroscience, 12, 114. https://doi.org/10.3389/FNCEL.2018.00114
35.
VelissarisD.ZareifopoulosN.KaramouzosV.KaranikolasE.PierrakosC.KoniariI.KaranikolasM. (2021). Presepsin as a diagnostic and prognostic biomarker in sepsis. Cureus, 13(5), e15019. https://doi.org/10.7759/CUREUS.15019
36.
WangL. J.LiS. C.LiS. W.KuoH. C.LeeS. Y.HuangL. H.ChinC. Y.YangC. Y. (2022). Gut microbiota and plasma cytokine levels in patients with attention-deficit/hyperactivity disorder. Translational Psychiatry, 12(1), 76. https://doi.org/10.1038/S41398-022-01844-X
37.
YirmiyaR.GoshenI. (2011). Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain, Behavior, and Immunity, 25(2), 181–213. https://doi.org/10.1016/J.BBI.2010.10.015
